Category: Medicine

Novel orexin receptor agonist shows potential to improve wakefulness Eisai has presented new clinical data […]

First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex Bluejay Therapeutics has enrolled the […]

New partnership aims to fast-track mRNA therapies from lab to clinic Quotient Sciences and CPI […]

Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain lzeCure Pharma has presented new clinical […]

Survey reveals lack of awareness need for greater clarity

Trial explores regenerative macrophage therapy for liver disease Resolution Therapeutics has announced that the first […]

Blended solutions gain momentum and reveal untapped potential

Collaboration offers end-to-end support from donor sourcing to manufacturing eXmoor Pharma and Anthony Nolan: Cell […]

Deal covers biosimilars for gastroenterology, neurology and dermatology Polpharma Biologics has signed licensing agreements with […]

MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma Eli Lilly and Company has […]

New subcutaneous autoinjector offers at-home treatment option for patients Eisai and Biogen have announced FDA […]

The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application […]

Swedish biotech company Akiram Therapeutics has announced significant progress in its first clinical trial of […]

HUTCHMED has announced that Weiguo Su, CEO of the company, will take a leave of […]

Encare’s ERAS Interactive Audit System (EIAS) has earned qualification on the Mayo Clinic Platform_Solutions Studio […]

Eli Lilly and Company has announced that Anne White, executive vice president and president of […]

Novartis has reported that its experimental drug ianalumab met the primary goal in a phase […]

Top-rated pharmacies in northern Virginia for personalised fertility care Finding the right pharmacy to support […]

Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, […]

ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating tumour cell (CTC) […]

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab […]

Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call […]

Project aims to improve global immunisation through needle-free delivery Upperton Pharma Solutions has secured funding […]

Merck’s therapy becomes first authorised option for aggressive soft tissue tumours Merck has announced that […]

Lilly’s study finds tirzepatide delivers broader health improvements Eli Lilly has announced positive topline results […]

Company shifts focus to phase 3 VE303 trial in recurrent C. difficile infection Vedanta Biosciences […]

Promising results support global submissions and priority review by US FDA Genmab has announced that […]

Teva’s CGRP therapy becomes first approved option for children and adolescent Teva Pharmaceuticals has received […]

Nationwide competition to pilot new models of obesity support Eli Lilly and Company and the […]

Pirtobrutinib meets primary endpoint in CLL/SLL study Eli Lilly and Company has announced positive topline […]

New treatment option now available across all UK nations Patients in Scotland with relapsed or […]

New phase of development targets chronic pain and fibromyalgia Sever Pharma Solutions has deepened its […]

Celltrion’s biosimilar now fully aligned with ACTEMRA IV indications in US Celltrion has received US […]

New first-line option for patients with pMMR and dMMR tumours in England NICE has recommended […]

FDA validation and AI-designed therapies mark major shift in treatment strategy Porosome Therapeutics has announced […]

New oral GLP-1 agonist aims to reshape chronic weight management Nxera Pharma has launched a […]

Dydrogesterone-only tablet returns after 17-year absence to support personalised care Gedeon Richter UK has launched […]

New drug delivery system could transform treatment for chronic conditions Scientists at the University of […]

MB310 study investigates safety and efficacy of precision microbiome therapy Microbiotica has completed patient recruitment […]

US$30.9 million strategic equity deal strengthens oncology platform Everest Medicines has announced a strategic equity […]

Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season Moderna has received marketing authorisation […]

Four-year treatment slows cognitive decline with consistent safety profile Eisai has presented new clinical data […]

Imfinzi and Imjudo combination recommended as first-line treatment AstraZeneca has received a positive recommendation from […]

Alfasigma to seek regulatory approval following OLINGUITO study success Alfasigma has announced positive topline results […]

Still time to enter – but not much! Enter The 2025 PharmaTimes Clinical Researcher of […]

CLEAR-DE study to assess topical therapy for non-proliferative diabetic retinopathy Exonate has announced plans to […]

Veranova has appointed Elizabeth Rebeil as VP of Supply Chain Excellence Veranova has appointed Elizabeth Rebeil as Global Vice President of […]

CHMP recommends authorization for LP.8.1-targeting vaccine ahead of 2025-2026 season Moderna has received a positive […]

Collaboration aims to advance next-generation therapeutics and vaccines Kling Bio has announced a new collaboration […]

Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator […]

Irish biotech’s germ-free egg platform could help close global shortfall Irish biotech Ovagen has announced […]

First patient dosed in phase 1b/2a study of procizumab 4TEEN4 Pharmaceuticals has dosed the first […]

Enter this year’s thrilling competition! Enter The 2025 PharmaTimes Clinical Researcher of the Year – […]

GlueSEEKER enables rational design of targeted protein degraders PhoreMost has published new data validating its […]

EC grants conditional marketing authorisation to Merck and SpringWorks Therapeutics The European Commission has approved […]

Clinical results from phase 2 study highlight analgesic effects in neuropathic pain patients AlzeCure Pharma […]

Funding to accelerate development of AI-driven tumour profiling tool OneMap One Biosciences has secured €15 […]

First patient dosed in BUOY-1 study targeting MDD with or without anxious distress Seaport Therapeutics […]

Digital operating rooms and histotripsy therapy combine to improve outcomes Proximie has announced a new […]

Healthinote rollout aims to improve early detection and patient self-management North East and North Cumbria […]

Sebetralstat offers injection-free relief for patients aged 12 and over The MHRA has approved sebetralstat […]

Vertex’s once-daily triple therapy approved for eligible patients aged six and over Vertex Pharmaceuticals has […]

Researchers at Imperial College London have discovered that an unusual DNA structure could be key […]

New treatment targets BRAFV600E-mutant mCRC after prior therapy Pierre Fabre Laboratories have received marketing authorisation […]

OVX836 shown to be safe and effective alongside seasonal Fluarix Tetra Osivax has released phase […]

New regulations aim to simplify processes and strengthen patient safety The Government is set to […]

Funding to support lead candidate targeting FAP and pipeline expansion Actithera has secured $75.5 million […]

BX004 achieves 500-fold bacterial reduction with no resistance in phase 1b/2a study BiomX has published […]

Enter the 2025 PharmaTimes Clinical Researcher of the Year – The Americas Enter The 2025 […]

New trial to test VMX-C001’s effectiveness in restoring coagulation in FXa DOAC patients Biotech company […]

SMC approval provides option for postmenopausal women at risk of fractures The Scottish Medicines Consortium […]

PulseSight begins phase 1 safety study of gene therapy for geographic atrophy PulseSight Therapeutics has […]

CSL Behring marks new era in treatment with milestone reimbursement model The first haemophilia B […]

Clinigen has appointed Paul Carter as Non-Executive Chair of its Board Clinigen, the global pharmaceutical services […]

Pneumagen’s intranasal antiviral demonstrates reduced infection Pneumagen has announced the publication of phase 2 data […]

Enhanced Genomics appoints Dr Dietrich Stephan as Chair of the Board Enhanced Genomics has appointed Dr Dietrich Stephan as […]

Data shows mRNA-1010 could better protect adults aged 50 and above Moderna has reported positive […]

Closed Loop Medicine has appointed Kate Woolland as CEO Closed Loop Medicine (CLM) has appointed Kate Woolland as […]

New data show strong efficacy of CD388 in phase 2b trial Cidara Therapeutics and hVIVO […]

Positive trial results offer hope for those with ultra-rare epileptic disorder UCB has announced that […]

Transforming community prescribing through innovation As the NHS places an increasing focus on strengthening primary […]

Why supporting representative trial participation matters

This year’s event took place on 11 to 12 June at Manchester Central This year’s […]

VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer. In […]

Enter this year’s famous competition Enter The 2025 PharmaTimes Clinical Researcher of the Year – […]

The programme was unveiled at this year’s NHS ConfedExpo in Manchester PMGroup Worldwide and Visions4Health […]

Biocartis has appointed Ben Svarczkopf as Senior Vice President of Global Marketing Biocartis Group of […]

The pilot will see GP practices look at patient records to identify those most at […]

Kallikor has appointed Chris Brett as Chief Technology and Product Officer Kallikor has announced the […]

Signadori is advancing a platform designed to overcome the challenges of treating solid cancers eXmoor […]

Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer Aravax has announced the […]

The candidate is being evaluated as both a monotherapy and in combination pembrolizumab Teva Pharmaceutical […]

iOnctura has appointed Steven Sciuto as Chief Financial Officer iOnctura has announced the appointment Steven […]

Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US The US Food […]

Results suggest bispecific antibody combination could improve outcomes A new investigational treatment has shown strong […]

Collaboration aims to improve rapid detection and personalised treatments EDX Medical Group has entered into […]

Tozaro has appointed Dr Jason Slingsby as Chief Executive Officer Tozaro has announced the appointment of Dr Jason Slingsby as Chief […]

Rheumatology studies show promising results for Sjogren’s disease Argenx has presented positive phase 2 results […]

EMHA calls for its inclusion in EU neurological health strategy The European Migraine and Headache […]

Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data […]

Three-year data highlights inflammation control in psoriatic arthritis UCB has announced new three-year data from […]

Personalisation is the future of cancer care

Clinigen has appointed Nihad Hasagic as SVP for CLS Clinigen has appointed Nihad Hasagic as Senior Vice President for Clinigen Lifecycle […]

Biotech firm to collaborate with NHS on early detection study Tagomics has been awarded £860k […]

Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas! Enter The 2025 […]

Tozaro has announced the appointment of Dr Jason Slingsby as Chief Executive Officer. Jason will lead the company’s […]

New funding supports development of diagnostic platform Birmingham spin-out Linear Diagnostics has secured £1m funding […]

Therapy indicated for children aged 3 to 14 at treatment initiation Santen has announced that […]

Treatment provides option for children with growth failure The National Institute for Health and Care […]

Last month, I had the privilege of hosting a webinar for the National Institute for […]

Richard Condon, CEO Aspire Pharma, discusses successful leadership

Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas! Enter The 2025 […]

Updated guidance from NICE expands eligibility for dapagliflozin us The National Institute for Health and […]

New guidance expands treatment options for eligible patients The National Institute for Health and Care […]

Worldwide Clinical Trials has appointed Stephen Rayda as Chief Digital and Information Officer Worldwide Clinical […]

The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise Lumanity […]

Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of […]

TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through […]

Company secures regulatory approvals for commercial rollout in UK and US With over 55 million […]

First non-immunosuppressive dual-action therapy approved for eligible patients The National Institute for Health and Care […]

Biotech spin-off targets fibrosis, neoplasm and neovascularization Massalia Therapeutics, a biotechnology spin-off from the C2VN […]

Strategic collaboration aims to improve early diagnosis Sonrai Analytics and AOA Dx have announced a […]

The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland […]

Kelso Pharma has appointed Bee Koen Low as Chief Operating Officer Kelso Pharma has announced […]

The drug was recently approved in the US for familial chylomicronaemia syndrome Ionis Pharmaceuticals has […]

Veranova has appointed Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence […]

Brekiya is now the first DHE auto-injector to be approved by the regulator The US […]

Regulator confirms safety and efficacy of new treatment option for patient The Medicines and Healthcare […]

Aspire-FTD study aims to stop disease progression with one-time treatment AviadoBio has launched its phase […]

Asgard Therapeutics has appointed Shane Olwill as Chief Development Officer Asgard Therapeutics, a privately held biotech company […]

FDA recognises KER-0193 as a potential therapy for rare paediatric disease Kaerus Bioscience has received […]

Trial progresses towards topline data expected later in the year Herantis Pharma has dosed the […]

Screening begins for study evaluating LTI-03 in idiopathic pulmonary fibrosi Rein Therapeutics has begun screening […]

Ellab has appointed Gergely Sved as its new Chief Executive Officer Ellab, the provider of validation, monitoring […]

Private equity firm Apiary Capital backs rapid growth of performance-i Apiary Capital has completed its […]

Fiona Smith-Laittan has been appointed Chair of Cambridge Global Health Partnerships Fiona Smith-Laittan, Vice President […]

Study explores whether PI3Kδ targeting could combat resistance iOnctura has begun a randomized phase 1/2 […]

Teprotumumab approved as first targeted treatment for thyroid eye disease The UK’s Medicines and Healthcare […]

Demonstrate your skill and prowess by entering this year’s awards! For 2025, The 2025 PharmaTimes […]

UCB’s developmental treatment may be eligible for patient access UCB has announced that its developmental […]

Company seeks approval for new schedules to improve patient convenience Janssen-Cilag International NV, a Johnson […]

New initiative aims to accelerate diagnosis and ease NHS pressures Chiesi UK and Ireland and […]

Cambridge firm in-licenses two oncology programmes Mosaic Therapeutics a UK-based oncology company has announced it […]

Approval marks milestone for AI use in frontline care NICE has endorsed DERM, an autonomous […]

Application seeks reduced infusion frequency to support patient flexibility Eisai Europe and Biogen Idec have […]

Study paves the way for personalised therapies for osteoarthritis sufferer Groundbreaking research has identified over […]

New therapy offers hope for patients with limited option Regeneron Pharmaceuticals has announced that the […]

Today’s leaders are building a stronger, more inclusive future for the industry

CHMP recommendation brings new hope for patients Takeda has announced a positive opinion from the […]

Aspire Pharma has appointed Katharina Pink as Chief Commercial Officer Aspire Pharma has announced the […]

VYVGART could be the first CIDP drug with a novel mechanism in 30 years Argenx […]

Kymera Therapeutics has appointed Noah Goodman as Chief Business Officer Clinical-stage biopharma Kymera Therapeutics has […]

Terumo BCT has appointed Patrick Daly as Chief Business Officer Terumo Blood and Cell Technologies […]

MHRA authorises drug for adults with rare heart muscle damage The Medicines and Healthcare products […]

Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes […]

Where to purchase reliable pharmacy automation systems Technological advancements propel the pharmaceutical industry into the […]

It is hoped that the MAGIC-I study will support earlier diagnosis and personalised treatment A […]

The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK Researchers […]

ABPI has appointed Russell Abberley as President-elect The Association of the British Pharmaceutical Industry (ABPI) […]

The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine Novavax has shared […]

Oncodesign Services has appointed Aidan Synnott as CEO Oncodesign Services has announced the appointment of […]

More than 37 million adults in the US are affected by migraine The US Food […]

New real-world data reinforce treatment benefit Real-world data from the University of Catania, Italy, suggest […]

European Commission grants authorisation for Eisai and Biogen therapy The European Commission has granted marketing […]

Studies show improved bone mineral density and healthcare cost reductions New data from multiple countries […]

Long-term survival projections suggest improved outcomes for patients New data from Janssen-Cilag International NV suggest […]

Birmingham researchers to make MGUS monitoring more efficient Birmingham researchers have received £230k from Cancer […]

Major update aims to accelerate research and strengthen patient safety New UK clinical trials regulations […]

The model could lead to more targeted treatments for the disease Cancer Research scientists have […]

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with […]

AI-powered SkyMind is designed to improve efficiency, compliance and decision-making SkyCell has partnered with Microsoft […]

An estimated 7.5 million people will be invited to receive the booster The NHS has […]

Angelini Ventures has appointed Regina Hodits as managing director Angelini Ventures has announced the appointment […]

Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK The […]

The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe […]

Research targets lysosomal function restoration for neurodegeneration Endlyz Therapeutics has launched from stealth, unveiling its […]

Women are shaping new dimensions throughout industry Having women in the pharmaceutical industry is crucial […]

Women in healthcare and pharma – progress, challenges and outcomes

Collaboration introduces automation to enhance efficiency Elekta has announced a partnership with Azra AI to […]

Approval extends ustekinumab’s use to younger patients The European Commission (EC) has approved ustekinumab for […]

Advancing care for stage 3 or 4 Hodgkin lymphoma patients The National Institute for Health […]

GMP certification enables 4basebio to supply DNA for clinical trials 4basebio PLC has been granted […]

Are biotechs underestimating regulatory groundwork

Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to […]

When Integrated DNA Technologies (IDT) launched its Collab Network in February 2023, the goal was […]

The vital link between human and animal well-being The next pandemic will require crucial collaboration […]

Janssen drug combination extends life expectancy during trial Janssen-Cilag International NV has announced results from […]

New therapy developed to repair GJB2 R75W mutation Scientists from Juntendo University and The University […]

Sygnature Discovery has appointed Kieron Hall as Chief Commercial Officer Sygnature Discovery has announced the appointment of Kieron Hall as its […]

NOUS-209 shows potential to intercept cancer in its early stages Nouscom has announced full safety […]

Drug Safety Research Unit appoints Linda Härmark as its Director The Drug Safety Research Unit has announced Linda Härmark as […]

Nuclera has appointed Seth Benson as Chief Financial Officer Nuclera, the biotechnology company accelerating protein expression and […]

iOnctura has appointed Elizabeth Holt as Chief Business Officer iOnctura has announced the appointment of […]

Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants The World Health Organization (WHO) […]

Collaboration brings remote care to cancer patients Careology and Entia have announced a partnership to […]

Aragen has appointed Manjunath Ramarao as Chief Scientific Officer Aragen has announced the appointment of […]

The update is aimed at strengthening local and national surveillance The UK Health Security Agency […]

Elekta has appointed Jonas Bolander as Acting President and CEO Elekta has announcement the appointment […]

The company is preparing to submit the results to the FDA this year Orca Bio […]